DK0749435T3 - Middel til dæmpning af interferens til anvendelse i immunoassays - Google Patents

Middel til dæmpning af interferens til anvendelse i immunoassays

Info

Publication number
DK0749435T3
DK0749435T3 DK95912194T DK95912194T DK0749435T3 DK 0749435 T3 DK0749435 T3 DK 0749435T3 DK 95912194 T DK95912194 T DK 95912194T DK 95912194 T DK95912194 T DK 95912194T DK 0749435 T3 DK0749435 T3 DK 0749435T3
Authority
DK
Denmark
Prior art keywords
immunoassays
agent
attenuating interference
streptavidin
interference
Prior art date
Application number
DK95912194T
Other languages
Danish (da)
English (en)
Inventor
Frederic Donie
Rosemarie Kientsch-Engel
Michael Wiedmann
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Priority claimed from PCT/EP1995/000776 external-priority patent/WO1995023801A1/fr
Application granted granted Critical
Publication of DK0749435T3 publication Critical patent/DK0749435T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/825Pretreatment for removal of interfering factors from sample
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807Hapten conjugated with peptide or protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
DK95912194T 1994-03-05 1995-03-03 Middel til dæmpning af interferens til anvendelse i immunoassays DK0749435T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4407423A DE4407423A1 (de) 1994-03-05 1994-03-05 Entstörmittel zum Einsatz bei Immunoassays
PCT/EP1995/000776 WO1995023801A1 (fr) 1994-03-05 1995-03-03 Produit de suppression des interactions dans les dosages immunologiques

Publications (1)

Publication Number Publication Date
DK0749435T3 true DK0749435T3 (da) 2001-01-02

Family

ID=6511991

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95912194T DK0749435T3 (da) 1994-03-05 1995-03-03 Middel til dæmpning af interferens til anvendelse i immunoassays

Country Status (11)

Country Link
US (1) US5952185A (fr)
EP (2) EP0697021B1 (fr)
JP (1) JP2750003B2 (fr)
KR (1) KR100252688B1 (fr)
CN (1) CN1102594C (fr)
AT (2) ATE194349T1 (fr)
DE (3) DE4407423A1 (fr)
DK (1) DK0749435T3 (fr)
ES (1) ES2152392T3 (fr)
PT (1) PT749435E (fr)
WO (1) WO1995023800A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19637718A1 (de) 1996-04-01 1997-10-02 Boehringer Mannheim Gmbh Rekombinante inaktive Core-Streptavidin Mutanten
US6410692B2 (en) * 1998-02-02 2002-06-25 Novadx, Inc. Removal of abundant interfering proteins from a liquid sample using a collapsible affinity matrix
US7166478B2 (en) * 2002-03-12 2007-01-23 Enzo Life Sciences, Inc., C/O Enzo Biochem, Inc. Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
US7172877B2 (en) * 2003-01-09 2007-02-06 Massachusetts Institute Of Technology Methods and compositions for peptide and protein labeling
US20050112586A1 (en) * 2003-11-24 2005-05-26 Roland Janzen Method and composition for stabilizing liquid reagents
WO2011127136A1 (fr) * 2010-04-06 2011-10-13 University Of Chicago Compositions et procédés liés à la modification de 5-hydroxyméthylcytosine (5-hmc)
KR101988600B1 (ko) * 2011-06-29 2019-06-12 가부시키가이샤 엘에스아이 메디엔스 비특이 반응 억제제, 비특이 반응 억제 방법 및 키트
EP3176580A1 (fr) 2015-12-01 2017-06-07 Roche Diagnostics GmbH Procédé de réduction d'interférences dans des dosages immunologiques
WO2018071813A1 (fr) * 2016-10-13 2018-04-19 Laboratory Corporation Of America Holdings Dispositifs et procédés permettant la réduction de composés interférents dans des échantillons biologiques
CN106950363A (zh) * 2017-03-31 2017-07-14 四川迈克生物科技股份有限公司 抑制类风湿因子干扰的胶乳增强免疫比浊试剂
WO2020068541A1 (fr) 2018-09-25 2020-04-02 Siemens Healthcare Diagnostics Inc. Procédés et compositions pour éliminer l'interférence de la biotine dans des dosages au moyen de pièges moléculaires
JP7245907B2 (ja) 2018-09-25 2023-03-24 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド 共役分子トラップを使用して、アッセイからビオチン干渉を取り除く方法および組成物
CN111122842A (zh) * 2018-10-31 2020-05-08 博阳生物科技(上海)有限公司 一种抗干扰剂及其应用
US12607625B2 (en) 2018-12-06 2026-04-21 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Method for eliminating interference of theophylline in immunoassay and immunoassay kit
WO2020113521A1 (fr) * 2018-12-06 2020-06-11 深圳迈瑞生物医疗电子股份有限公司 Procédé d'élimination de l'interférence de la doxorubicine dans un dosage immunologique et kit de dosage immunologique
CN110146692A (zh) * 2019-05-28 2019-08-20 迪瑞医疗科技股份有限公司 一种基于吖啶酯化学发光、链霉亲和素磁珠-生物素放大反应体系及检测试剂盒
JP7714330B2 (ja) * 2020-09-08 2025-07-29 デンカ株式会社 偽陽性の抑制により特異性を改善した検査キット
CN112595845B (zh) * 2020-12-09 2022-10-21 深圳普门科技股份有限公司 透明质酸检测试剂盒及检测系统
CN113740526B (zh) * 2021-08-20 2024-02-20 广西康柏莱科技有限公司 一种改性封闭剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0155854B1 (fr) * 1984-03-22 1990-09-26 Bresatec Limited Matériel de test biologique non-radioactif
US4914040A (en) * 1988-03-03 1990-04-03 Boehringer Mannheim Gmbh Reagent and method for determination of a polyvalent substance using an immunoaggregate
US5395938A (en) * 1992-08-21 1995-03-07 Nichols Institute Diagnostics Biotinylated chemiluminescent labels and their conjugates, assays and assay kits
DE4302241A1 (de) * 1993-01-27 1994-07-28 Boehringer Mannheim Gmbh Neues Biotinylierungsreagenz

Also Published As

Publication number Publication date
EP0749435B1 (fr) 2000-10-11
WO1995023800A1 (fr) 1995-09-08
DE59508529D1 (de) 2000-08-10
DE59508786D1 (de) 2000-11-16
ATE196906T1 (de) 2000-10-15
US5952185A (en) 1999-09-14
KR100252688B1 (ko) 2000-05-01
JPH08508301A (ja) 1996-09-03
CN1102594C (zh) 2003-03-05
ES2152392T3 (es) 2001-02-01
EP0697021A1 (fr) 1996-02-21
CN1143368A (zh) 1997-02-19
ATE194349T1 (de) 2000-07-15
EP0749435A1 (fr) 1996-12-27
DE4407423A1 (de) 1995-09-07
JP2750003B2 (ja) 1998-05-13
EP0697021B1 (fr) 2000-07-05
PT749435E (pt) 2001-03-30

Similar Documents

Publication Publication Date Title
DK0749435T3 (da) Middel til dæmpning af interferens til anvendelse i immunoassays
YU40997A (sh) Novi oksadiazoli, postupci za njihovo pripremanje
NO952396L (no) Amino-substituerte pyrazoler med CRF antagonistisk virkning
ES2189968T3 (es) Amidinofenil-pirrolidinas,-pirrolinas,e -isoxazolidinas y derivadOS DE LOS MISMOS.
MY102842A (en) Calcium independent camp phosphodiesterase inhibitor antidepressant
AR038427A2 (es) Compuestos 15-alquil-14-hidroxilo de marcfortina y parahercuamida
MY120511A (en) New pesticides
ES2138247T3 (es) Composicion y uso.
AU7533091A (en) N-(3-fluoro-2-phosphonylmethoxypropyl) derivatives of purine and pyrimidine heterocyclic bases, their preparation and use
MX9203331A (es) Derivados de pirimidina-4-carboxamida, su preparacion y su aplicacion en terapeutica.
MX9601112A (es) Nuevas composiciones herbicidas.
TW324009B (en) Pyrazole condensation ring derivative, its production process and its use as androgen inhibitor
HUP0001781A2 (hu) Szubsztituált pirazolil-pirazol-származékok és herbicidként történő alkalmazásuk
MX9701949A (es) Derivados de distamicina substituidos con bis-(2-haloetil) aminofenilo como agentes antitumorales y antivirales.
HU9601646D0 (en) 4-benzoylisoxazoles and their use as herbicides
DE69420267D1 (de) Verringerung des interferometrischen rauschen eines optischen netzwerks
ES8705421A1 (es) Un procedimiento para la preparacion de 4-amino-2-fenil-quinolinas
ATE31295T1 (de) Benzoylharnstoffderivate.
DK0532629T3 (da) 1-Piperidinyl-alkanoylarylsulfonamid-derivater
ES2080336T3 (es) Derivados de metilpiperazinoazepina, su preparacion y su utilizacion.
MX9204194A (es) Los compuestos de 1,2,4-oxadiazolil-fenoxialquilisoxazolas y su uso como agentes antivirales
BR9407232A (pt) Compostos de tiocarbamoíla
ATE65986T1 (de) Propanolabkoemmlinge.
ES471208A1 (es) Procedimiento para la preparacion de nuevos derivados con- densados de pirimidina
ATE113034T1 (de) 3-(2-chloro-4-trifluoromethyl-phenoxy)-1- azetidinkarboxamide mit antikrampfmachender aktivität.